Autologous anti-tumor lymphocytes

tumor-reactive autologous lymphocytes · National Cancer Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous anti-tumor lymphocytes, covering 2013-05-27 to 2013-05-27. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma [Phase 2]

See pricing